Download as pdf or txt
Download as pdf or txt
You are on page 1of 6

Navigating the intricacies of writing a thesis can be a daunting task, particularly when dealing with

complex topics such as NF-kB. The NF-kB pathway is a crucial regulator of immune responses and
inflammation, making it a focal point of research in various fields including immunology, oncology,
and neurobiology.

Crafting a thesis on NF-kB requires a deep understanding of its molecular mechanisms, signaling
pathways, and its implications in disease processes. Moreover, synthesizing and analyzing existing
literature, designing experiments, and interpreting results add layers of complexity to the task.

One of the biggest challenges in writing a thesis on NF-kB is the need for comprehensive literature
review and staying updated with the latest research findings. Additionally, conducting experiments
to generate novel data can be time-consuming and require meticulous planning and execution.

For students and researchers grappling with the complexities of writing a thesis on NF-kB, seeking
expert assistance can be invaluable. ⇒ HelpWriting.net ⇔ offers professional thesis writing
services tailored to meet the specific needs of individuals tackling this challenging topic.

By entrusting your NF-kB thesis to ⇒ HelpWriting.net ⇔, you can benefit from their team of
experienced writers and researchers who possess in-depth knowledge of NF-kB and related fields.
Their expertise can help streamline the writing process, ensuring clarity, accuracy, and coherence in
your thesis.

Don't let the complexities of writing a thesis on NF-kB overwhelm you. Order your thesis from ⇒
HelpWriting.net ⇔ today and take the first step towards academic success.
NF-kB is a key transcription factor that is involved in immune and inflammatory responses,
developmental processes, cellular growth and apoptosis. Journal of Otorhinolaryngology, Hearing
and Balance Medicine (JOHBM). Signaling molecules of the NF-kappa B pathway shuttle
constitutively between cytoplasm and nucleus. Transcription factors of the nuclear factor ?B (NF-
?B) family are central coordinating regulators of the host defence responses to stress, injury and
infection. Based on the currently available clinical and immunological data, the causative relation
between defined NFKB1 mutations and EBV infections or associated disease remains unclarified.
Although genetic alterations of NF-?B and I?B themselves have not yet been reported to be
associated with these diseases, aberrant, constitutive NF-?B activity could be caused by defects in
the regulatory mechanisms controlling NF-?B activation. The Article Processing Charge (APC) for
publication in this open access journal is 2600 CHF (Swiss Francs). Virus-induced lymphocyte
expansion is tackled by application of various immunosuppressants. Combined deficiency in
IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer
cell differentiation. This article must therefore be hereby markedadvertisementin accordancewith 18
U.S.C. Section 1734 solely to indicate this fact.1 This work supported by the Melanoma and Skin
Cancer Research Institute, Sydney,Australia, and New South Wales State Cancer Council, New
South Wales, Australia.2 Address correspondence and reprint requests to Dr. Peter Hersey,
Department ofOncology and Immunology, Room 443, David Maddison Building, Corner of
Kingand Watt Streets, Newcastle, NSW 2300, Australia. Activation of this pathway depends on the
signal-induced stabilisation of NIK and subsequent NIK-mediated phosphorylation of IKK. In
addition, administration of interleukin-7 was reported to expand virus-specific cytotoxic T cells ( 83
). X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-?B
signaling. Platelet NF-?B might also be involved in regulating miRNA, however, this requires further
validation. However, the mechanisms underlying this effect remain hypothetical. Department of
Oncology and Immunology Unit, David Maddison Clinical SciencesBuilding, Newcastle, New
South Wales, Australia Received for publication April 12, 2000. This pathway involves activation of
the I?B kinase (IKK) complex (IKK?, IKK?, and IKK?) by TAK1 and IKK-mediated I?B. In
cotransfection experiments with the GFP vector, apoptosis was as-sessed in cells gated for green
fluorescence by annexin V conjugated withPE (BD PharMingen). Activation occurs at the surface of
the mitochondria. Once you are registered, click here to go to the submission form. Given the
relatively low concentration of theGFP vector, it was safe to assume the GFP-containing cells
alsowere transfected with the mutant IkBa vector. Consequently, aberrant NF-?B activation has been
described in a variety of lymphoid malignancies, including diffuse large B-cell lymphoma, Hodgkin
lymphoma, and adult T-cell leukemia. However, the mechanisms underlying this effect remain
hypothetical. Postrepression activation of NF-?B requires the amino-terminal nuclear export signal
specific to I?B. NF-?B Activation: Canonical and non-canonical pathways. Collectively, such
affected targets include cytokines and chemokines, T-cell receptor and toll-like receptor subunits, T-
cell activation and differentiation markers, cell adhesion molecules, stress response factors, growth
factors and regulators of apoptosis, and numerous transcription factors and signaling molecules.
Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. Degradation
of I?Bs allows translocation of NF-?B into the nucleus and bind to their cognate DNA binding sites
to regulate the transcription of large numbers of genes including antimicrobial peptides, cytokines,
chemokines, stress response proteins, and antiapoptotic proteins. Moreover, thrombin triggers ADP
release, TXA 2 production, and I?B. Practice reproducing the analyses yourself: 2 Factor Between (2
levels x 2 levels).sav 2 Factor Between (2 levels x3 levels).sav 3 Factor Between (2 levels x 2 levels x
2 levels).sav 2 Factor Within (2 levels x 2 levels).sav All on Portal.
Cells in suspension were added on the day of theassay. Italso was noted that treatment of
melanocytes, fibroblasts, and rest-ing PBL with even high concentrations of LLnL did not makethem
sensitive to TRAIL-induced apoptosis. This domain is responsible for dimerization and DNA-
binding abilities of the mature p50 subunit. Feature papers are submitted upon individual invitation
or recommendation by the scientific editors and must receive. Therabbit Ab against p50 was
purchased from Fitzgerald (Concord, MA). Components and mechanisms ensuring signal
transduction in this pathway are depicted, with black arrows indicating ubiquitination processes and
grey arrows phosphorylation. Three family members, p65, cRel and RelB, contain transcriptional
activation domains (TAD) at their C-terminus, and are therefore able to directly activate
transcription. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
Inhibition of USP47 might be a suitable strategy to downregulate NF-?B activity, and to overcome
chemoresistance in gastric cancer. The medium and PBS were placed in 123 75 mmFalcon
polystyrene tube and centrifuged at 2003 g. Comparison of diagnostic criteria for common variable
immunodeficiency disorder. We found that USP47 contributes to cell viability and chemoresistance
in NCI-N87 gastric carcinoma cells treated with etoposide and camptothecin. As NF-?B’s central role
in human physiology prohibits its global inhibition, these auxiliary or cell type-specific NF-?B
regulating pathways are potential therapeutic targets. Key positive regulators of NF-?B signaling can
act as oncogenes that are often prone to chromosomal translocation, amplifications, or activating
mutations. TRAIL-RI TRADD Recruits and permits caspase-8 transactivation. Mutations of CD40
gene cause an autosomal recessive form of immunodeficiency with hyper IgM. We are currently
exploring the involvement of other NF-kappa B and cell death regulating proteins in human cancer.
Components and mechanisms ensuring signal transduction in this pathway are depicted on the left,
with black arrows indicating ubiquitination processes and grey arrows phosphorylation. Feature
papers represent the most advanced research with significant potential for high impact in the field. A
Feature. An induced proteolysis of RIPK1, in addition to its deubiquitination, is indicated although
its relevance in NF-?B signaling is uncertain. Color code: color of the arrow refers to the protein
concerned by the depicted action. These studies showed that thetransfected melanoma cells had
increased sensitivity to TRAIL-induced apoptosis and decreased binding of NF-kB proteins in
thenucleus. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. You will be
able to get a quick price and instant permission to reuse the content in many different ways. Similarly,
other clinical manifestations such as autoinflammatory syndromes do not correlate with clustering of
mutations on protein domains (Figure 2 ). NEMO is located on the X chromosome and its mutations
are associated with two human disorders: incontinentia pigmenti and anhidrotic ectodermal dysplasia
with immunodeficiency. 27, 28 Similarly, heterozygous NEMO female mice develop granulocytic
infiltration and hyperproliferative keratinocytes with increasing apoptosis. 29, 30 Currently, the
mechanism by which NEMO regulates the NF-?B pathway remains poorly understood. NF-kB is
known to activate a number of genescoding for proteins that inhibit apoptosis by the
transmembranesignaling pathway (18, 43) and mitochondrial stress pathway (20, 44). Activation of
the transcription factor NF-kB maybe one of the main pathways involved in the latter, as it is
knownto be activated by TRAIL-R4 (17) and, paradoxically, also bydeath receptors for TRAIL (8).
NF-?B activation provides the potential link between inflammation and hyperplasia in the arthritic
joint. Submitted papers should be well formatted and use good English.
Silencing ELKS expression by RNA interference blocked induced expression of NF-?B target genes,
including the NF-?B inhibitor, I?B?, proinflammatory genes such as cyclo-oxygenase 2 and
interleukin (IL)-8. Please note that many of the page functionalities won't work as expected without
javascript enabled. Severe liver degeneration in mice lacking the I?B kinase 2 gene. K48-linked
polyubiquitination is indicated with brown hexagons. Activated NF-?B plays a role in platelet
survival and platelet priming. The left column shows their role in regulation of the canonical (core),
non-canonical, or atypical NF-?B pathways and some additional information on their established
functions according to (Perkins, 2007). Evident above, there is a scarcity of data on drug
pharmacodynamics at the level of platelet NF-?B, as compared to NF-?B in other cells. Although, a
detailed understating of how these transcription factors respond to their cognate stimulus is well
established, it is now appreciated that HIF and NF-?B undergo extensive crosstalk, in particular in
pathological situations such as cancer. In particular, microfluidics can help in recreating the external
signals found in vivo. Activated CARMA1 in turn nucleates the formation of a fibrillary high-
molecular weight signaling complex (CBM complex) comprising long BCL10 filaments and MALT1.
You will be able to get a quick price and instant permission to reuse the content in many different
ways. Still, other mutations introducing early stop codons have been identified in the RHD domain
lacking an association with EBV infection ( 5, 6, 9, 10, 12 ). The NF-?B-miRNA transcriptional
regulatory network has been implicated in the regulation of proinflammatory, immune, and stress-like
responses. This domain is responsible for dimerization and DNA-binding abilities of the mature p50
subunit. Specifically, BRD4 binds acetylated RELA, which increases its transcriptional
transactivation activity and stability in the nucleus. In contrast, mutations of the downstream
components, such as the DNA-binding subunits, contribute to oncogenic transformation by affecting
NF-?B-driven transcriptional output programs. Here, we discuss the features of recently identified
oncogenic RelA fusion proteins and the characterization of pathways that are regulating the
transcriptional activity of NF-?B by regulatory phosphorylations. Interestingly, NF-kB turns on the
expression of its own repressor, IkBa. In parallel, the release of dense granules content including
ADP occurs, triggering further platelet recruitment and activation. This was con-firmed in the present
studies by gel shift assays, GFP reporterconstructs for NF-kB, and nuclear staining with Abs specific
forp50, p65, and p75. IL-1R: IL-1 receptor; TNFR: TNF receptor; NEMO (IKK?); ( Right ) In
contrast, prolonged exposure to NSAIDs in the absence of additional NF-?B activators stimulates
degradation of I?B and nuclear translocation of NF-?B. Cellswere washed either twice with PBS and
analyzed if directly labeled, or ifindirectly labeled, cells the were incubated with F(ab9)2 affinity-
isolatedFITC-conjugated sheep anti-mouse Ig (Silenus, cat. no. 985051020; AmradBiotech, Boronia,
Victoria, Australia) plus 20ml of 100% human serum to FIGURE 1. Still and all, further research is
mandatory to provide us with the facts. 6. The Interplay between mRNA, miRNA, and NF-?B in
Platelets As mentioned in Section 3, platelets harbor both mRNA and miRNA. Platelet NF-?B might
also be involved in regulating miRNA, however, this requires further validation. In view of this,
wetransfected a mutated degradation-resistant form of IkBa into themelanoma cells that specifically
inhibits activation of NF-kB bybinding the proteins in the cytoplasm. ADAPTIVE IMMUNITY
LYMPHOID ORGANS DEVELOPMENT, ANTIGEN PRESENTATION AND MAINTENANCE
OF MEMORY CELLS APCs, T and B lymphocytes. A nuclear export signal in the N-terminal
regulatory domain of I?B. M1- and K63-linked polyubiquitination is indicated with yellow and
green hexagons, respectively. In parallel, I?B? degradation and p65 phosphorylation were observed.
This was consistent with themarked increases in sensitivity to TRAIL-induced apoptosis in
theTRAIL-resistant sublines after treatment with LLnL to inhibit NF-kB. Nevertheless, wefound
previously that there was a large variation in response ofdifferent melanoma cell lines to TRAIL.
BET proteins contain two bromodomains (BD1 and BD2, respectively) and an extra-terminal
domain (ET). BRD4 can also bind acetylated lysines in histones or TF in enhancer elements, thereby
contributing to long-range control of gene activity (see text for details). Herein, our endeavors in
recapitulating diverse data on platelet NF-?B might help to characterize the exceptional function of
this protein in platelets. K48-linked polyubiquitination is indicated with brown hexagons. Journal of
Functional Morphology and Kinesiology (JFMK). In this review, we will focus on the current
knowledge regarding NSAID effects on the NF-?B signalling pathway in pre-cancerous and
cancerous lesions, and the evidence that these effects contribute to the anti-tumour activity of the
agents. Accordingly, the NF-?B pathway is widely considered an attractive therapeutic target in a
broad range of malignant and non-malignant diseases. Monoclonal Abs, recombinant proteins, and
peptides Recombinant human (hu) TRAIL (lot 6321-19) prepared as described else-where (4) and
huCD40L (lot 5753-56) were supplied by Immunex (Seattle,WA). NF-kB FUNCTIONS:
IMMUNITY (1) NF-kB INDUCERS ?Bacteria and Fungi ?Bacterial or Fungal Products ?Viruses
?Viral Products ?Eukaryotic parasite ?(Inflammatory) Cytokines ?Physiological (Stress) Conditions
?Physical Stress ?Oxidative Stress ?Environmental Hazards ?Therapeutically used drugs ?Modified
Proteins ?Overexpressed Proteins ?Receptor Ligands ?Apoptotic Mediators ?Mitogens, Growth
Factors and Hormones. Deficiency of innate and acquired immunity caused by an IKBKB mutation.
Franco, Xu Dong Zhang, Elisabeth Van Berkel, Jayne E. Immunotherapeutic effects of IL-7 during a
chronic viral infection in mice. The incidence of gastric cancer in the western world is slowly
declining, but the prognosis is unpromising. TRAIL-resistant sublines that were generated by
intermittent exposureto TRAIL were shown to have high levels of activated NF-kB, and resistance to
TRAIL could be reversed by LLnL and by thesuperrepressor form of IkBa. The number of amino
acids in each human protein is shown on right. The five NF-?B subunits are presented with their
functional domains. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. The combinatorial
occupancy of numerous genomic regions (enhancers and promoters) coordinates the transcriptional
activation or repression of hundreds of genes that collectively determine the balance between
metabolic and inflammatory phenotypes and the extent of apoptosis and autophagy or repair of cell
damage and survival. When noncanonical NF-?B is activated in C250T mutant cells, p52 can recruit
Ets transcription factors to the mutated TERT promoter and drive transcription. Essentially similar
results were found ina repeat of the study, with the exception of Mel-CV. Larger cohorts and a broad
investigation of cellular and genetic functionalities will be necessary to decipher this relationship.
Instead, it ap-peared from the NF-kB reporter assays that resistance to apoptosiscorrelated more with
the increase in the level of NF-kB activationafter exposure to TRAIL. Also in myeloma cells, RelA
and RelB containing dimers mediate expressions of overlapping set of anti-apoptotic genes. Multiple
myeloma(MM), an incurable plasma cell cancer, represents the second most prevalent hematological
malignancy. Stimulus-dependent acetylation of RELA at lysine-310 by p300 induces the recruitment
of BRD4 to the promoter via its bromodomains. NF-?B signaling pathways in mammalian and insect
innate immunity. IgR3, Mel-RM, and SK-MEL-28 hadmoderate sensitivity to TRAIL and
moderately high basal levels ofNF-kB, which was increased further by TRAIL. Additionally,
oncogenic MyD88 mutations can promote the activation of IKK. Therapeutic potential of inhibition
of the NF-kappaB pathway in the treatment of inflammation and cancer. Other non-antiplatelet and
non-anticoagulant compounds also exhibit modulatory actions against NF-?B.
Such findings suggest that NF-?B could contribute to platelet degranulation in platelet secretion.
Indeed, SNAREs play a major role in the fusion of platelet granules with the platelet membrane. An
intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. Upon
receptor activation, NIK is stabilized, leading to IKK. Therapeutic potential of inhibition of the NF-
?B pathway in the treatment of inflammation and cancer. Subcellular fractions were prepared at the
indicated time points and ?TrCP stability was analyzed in the cytosolic fractions. Girls homozygous
for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-
associated lymphoproliferation. In Germany, the 5-year-survival rate is around 32%, and the average
life span after diagnosis is 6 to 9 months. Biallelic loss-of-function mutation in NIK causes a primary
immunodeficiency with multifaceted aberrant lymphoid immunity. Reconstitution of IKK2, but not
IKK1, increased Mdm2 levels and decreased doxorubicin induced stabilisation of p53 and cell death.
Ralph (Department of Biochemistry and Molecular Biology, MonashUniversity, Victoria, Australia),
respectively. Activation occurs at the surface of the endoplasmic reticulum. Consequently, aberrant
NF-?B activation has been described in a variety of lymphoid malignancies, including diffuse large
B-cell lymphoma, Hodgkin lymphoma, and adult T-cell leukemia. A small molecule ubiquitination
inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. Color code: color of
the arrow refers to the protein concerned by the depicted action. Essential role of nuclear factor
kappaB in the induction of eosinophilia in allergic airway inflammation. Our data also distinguish
between the functions of the highly homologous kinases, IKK1 and IKK2, in response to
chemotherapy. The NF-?B pathway is not only a direct target but also a modulator of several
miRNAs. The number of amino acids is provided for human proteins. Here, we will also discuss
evidence for crosstalk between the NF-?B pathway and nucleoli, the role that this cross-talk has in
the anti-tumour effects of NSAIDs and ways forward to exploit this crosstalk for therapeutic
purpose. The alpha and beta subunits of I?B kinase (IKK) mediate TRAF2-dependent IKK
recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. These K63-linked
polyubiquitin chains as well as the linear polyubiquitin chains generated by the action of the LUBAC
allow the recruitment and activation of the IKK complex. Targeted disruption of the p50 subunit of
NF-kappa B leads to multifocal defects in immune responses. Also, the presence of modifying
factors, such as secondary mutations and epigenetic alterations, could be addressed in such enlarged
cohorts. An early response to stresses that induce nucleolar translocation of RelA is disruption of
nucleolar morphology, which may “prime” this organelle for nucleolar residency of RelA. All
melanoma cell lines werepositive for tyrosinase and MART-1 mRNA by RT-PCR tests
describedelsewhere (31), except for Mel-SP, which was positive for Tyrosinase butnot MART-1. At
first passage, switch to growth medium containing Puromycin. Data were filtered for genes regulated
by at least two-fold. The effects mediated by IKK2 required its kinase function and were abrogated
by coexpression of the dominant negative I?B?M, implying a role for NF-?B in blocking
chemotherapy induced p53 and cell death. 43.

You might also like